CEU Course Details


LIne number 78, 1082
PackageID= 0
package_CourseID= 9003
LIne number 135,num= 1
num11= 0
sql11= select * from tblUserScore where numScore >= ’75′ and numExamID = ’1082′ and numStudentID = ” and dtmDateTime > ’2019-05-30 11:05:22′ ORDER BY numScoreID DESC LIMIT 1
LIne number 141,ynArchived= 0
numCredits= 2
LIne number 190,query22 = select * from tblUserPayments where numStudentID = ” and numExamID = ’9001′ and dtmPaymentDate >= ’2019-05-30′ ORDER BY numPaymentID DESC LIMIT 1
pay= 1
pay= 1
ispckFound= 9
pckgStndRefSt= select * from package_student_ref where student_id =” AND expiry_date >’2019-05-30′
, numCredits= 2
LIne number 213,qry3= SELECT * FROM package_student_ref WHERE student_id = ” AND expiry_date >= ’2019-05-30′
PackExpire= 2019-05-30
nm3= 9
ynArchived= 0
LIne number 276,mysql_num_rows(res77)= 347
LIne number 312,packageID= 9001
LIne number 324,packageID= 9001

The Ethics of Elective Psychopharmacology

credit limit =
total earned credit = +
LIne number 868,packageID= 9001
Course Description:
This course is based upon material published in the International Journal of Neuropsychopharmacology and is available as an open access article on the creative commons website.
Abstract: Pharmacological cognitive enhancers (PCEs) are used to improve cognitive functions, such as attention, learning, memory and planning in patients with impairments in cognition resulting from traumatic brain injury (TBI) or from neuropsychiatric disorders such as Alzheimer’s disease (AD), mild cognitive impairment, schizophrenia, and attention deficit hyperactivity disorder (ADHD). Moreover, PCEs have been shown to improve cognition in healthy volunteers with no psychiatric disorders. This article describes the rationale behind the need for their use in neuropsychiatric patients and illustrates how PCE scan ameliorate cognitive impairments, improve quality of life and wellbeing, and therefore reduce the economic burden associated with these disorders. We also describe evidence that PCEs are being used as cognitive enhancers by healthy people. Crucially, as the lifestyle use of these drugs becomes very popular in the healthy population, a final aim is to present an overview of the current and future neuroethical considerations of enhancing the healthy brain. As information regarding their actual use, benefits and harms in various healthy populations is currently lacking, we propose research that aims to obtain relevant empirical data, monitor the short- and long-term effectiveness and side-effects, and initiate accurate surveys to determine current patterns and quantity of usage of PCE drugs by healthy people. Furthermore, in order to instigate a dialogue between neuroethics and neuropsychopharmacology, we urge scientists to explore and communicate the social and ethical implications of their research to the public. Finally, we discuss and highlight other means of enhancing cognition in both patients and healthy adults, including education and physical exercise.
This course on the ethics of elective psychopharmacology is useful for psychologists, nurses, social workers, professional counselors, and chemical dependency counselors who work with clients and need continuing education. This course is appropriate for beginning, intermediate and advanced level practitioners who wish to develop their understanding of ethics and elective psychopharmacology. It may also be useful for licensed clinicians who require ethics course credits and are interested in learning more about elective psychopharmacology.  
Authors: Mohamed and Sahakian
Learning Objectives: This course will provide the practitioner with detailed information regarding ethics and psychopharmacology. Specifically, a professional will:
·         Describe the rationale behind the need for the use of cognitive enhancers in neuropsychiatric patients
·         Identify uses of cognitive enhancers in patients with cognitive impairments and in healthy people.
·         Identify other means of enhancing cognition in both patients and healthy adults
Citation:   Mohamed and Sahakian. (2012). The ethics of elective psychopharmacology. International Journal of Neuropsychopharmacology. V 15 pp 559–571. Reviewed by TM DiDona, PhD 2018 and found to be current. For a full list of current references, please Click Here
buy = 0
LIne number 946,packageID= 9001
LIne number 1013,packageID= 9001
Line number 1050,pay=1, years=0, allowPrint=0
coup[Expires]=2021-03-23 20:49:17
sql22=select * from tblUserScore where numScore >= ’75′ and numExamID = “1082″ and numStudentID = “” and dtmDateTime > ’2019-05-30 12:00:00′ order by numScoreID desc limit 1
Line number 1098, years, months, days, hours, minuts, seconds50,5,12,0,0,0
Line number 1950
Take Exam
Get Course Materials

This Ce-Classes.com course is approved for CE credit by:

  • The American Psychological Association (APA) Ce-Classes.com is approved by the American Psychological Association to sponsor continuing education for psychologists. Ce-Classes.com maintains responsibility for this program and its content.
  • Association of Social Work Boards (ASWB) Ce-Classes.com, Provider #1142, is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved as ACE providers. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Ce-Classes.com maintains responsibility for this course. ASWB Approval Period: 1/5/2020-1/5/2023
  • Social workers participating in this course will receive 2 Clinical continuing education clock hours.
  • This course is NOT available for NBCC credit.

  • The Florida Board of Clinical Social Work, Marriage and Family Therapy and Mental Health Counseling Provider #852 BAP-Expires 3/31/2021
  • The California Board of Behavioral Sciences. The California Board of Behavioral Sciences, BBS, recognizes relevant course work/training that has been approved by nationally recognized certifying bodies, such as APA, to satisfy renewal requirements.
  • California Consortium of Addiction Programs and Professionals (CCAPP) Provider Number OS-12-147-0221 Expires 2-2021
  • The Texas Board of Social Work Examiners, Continuing Education Provider – 5674 expires 4/30/2021.
  • The Texas Board of Professional Counselors, Continuing Education Provider
  • Massachusetts Authorization Number: 1082
  • Ohio Counselor, Social Worker and Marriage and Family Therapist Board – Provider # RCST031201 Expires 5/31/2021
  • New York Social Work Board – Ce-Classes.com is recognized by the New York State Education Department’s State Board for Social Work as an approved provider of continuing education for licensed social workers #SW-0120.

  • The Florida Board of Nursing (CE Provider #: 50-4896) Expires 10/31/2020 Do not send certificates to the Florida Board of Nursing. You must keep this certificate for 4 years.
  • The California Board of Registered Nursing. CEP 15647 Expires 11/30/2020.

This course is Non Interactive .

If you would like to take this course for your CE program, it is recommended that you:

  1. Print this page
  2. Log In
  3. Click the “Get Course Materials” link above, if you do not currently possess the course material
  4. Answer the questions on this page as you study your course material
  5. Return to this page
  6. Click the Take Exam link above to purchase this course
  7. Submit your exam and score 75% – if you score lower, review your errors and retake exam.
  8. Click on the Print Certificate link
  9. Complete the course evaluation, (all items must be completed)
  10. Print your certificate

Some courses require Adobe Acrobat reader to be installed. If you do not have Adobe Acrobat Reader,

Download it here for FREE!

Approved by the Following Agencies

Not all courses are approved by each agency. See each individual course description for specific approval information.

Approved Provider